Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signalling.
Matthew BellShannon LangeBesian I SejdiuJorge Ibañez-VegaHao ShiXiang SunXiaoxi MengPhuong NguyenMorgan SuttonJessica WagnerAnil KcDeanna M LangfittSagar L PatilHaiyan TanRam Vinay PandeyYuxin LiZuo-Fei YuanAlejandro Allo AnidoMitchell HoHeather SheppardPeter VogelJiyang YuJunmin PengHongbo ChiM Madan BabuGiedre KrenciuteStephen GottschalkPublished in: Nature biomedical engineering (2023)
The limited availability of cytokines in solid tumours hinders maintenance of the antitumour activity of chimeric antigen receptor (CAR) T cells. Cytokine receptor signalling pathways in CAR T cells can be activated by transgenic expression or injection of cytokines in the tumour, or by engineering the activation of cognate cytokine receptors. However, these strategies are constrained by toxicity arising from the activation of bystander cells, by the suboptimal biodistribution of the cytokines and by downregulation of the cognate receptor. Here we show that replacement of the extracellular domains of heterodimeric cytokine receptors in T cells with two leucine zipper motifs provides optimal Janus kinase/signal transducer and activator of transcription signalling. Such chimeric cytokine receptors, which can be generated for common γ-chain receptors, interleukin-10 and -12 receptors, enabled T cells to survive cytokine starvation without induction of autonomous cell growth, and augmented the effector function of CAR T cells in vitro in the setting of chronic antigen exposure and in human tumour xenografts in mice. As a modular design, leucine zippers can be used to generate constitutively active cytokine receptors in effector immune cells.